Ui Investissement
Ui Investissement is an independent French private-equity firm investing alongside founders and management teams in French non-listed startups, SMEs and ETIs. It states that it invests as a majority or minority shareholder across capital development and transmission/LBO, innovation capital and consolidation.
What stands out about Ui Investissement
Ui Investissement publicly describes investments throughout France in non-listed companies, with principal sector areas of health, agro-business and services-industry. Its stated capital-development and LBO tickets range from €1 million to €50 million.[1][2][4][7]
What does Ui Investissement invest in?
Ui Investissement is an independent French private-equity firm investing alongside founders and management teams in startups, SMEs and ETIs. The firm states that it invests as a majority or minority shareholder and provides financial support and operational expertise to accelerate company development.[1][2]
Ui Investissement publicly identifies three investment activities: capital development and transmission/LBO, innovation capital and consolidation. Its strategy includes majority and minority investments, with financial and operational support for company development.[2]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Ui Investissement?
Owners evaluating Ui Investissement should clarify which investment activity and fund would apply, whether the contemplated transaction would be minority or majority, and how the stated €1 million-to-€50 million capital-development and LBO range applies to the company. The firm’s stated geographic model and sector focus may be relevant to companies operating in France in health, agro-business or services-industry.
Owners should also request the applicable revenue, EBITDA, valuation and ownership parameters, together with governance expectations, management-equity requirements, reporting obligations, ownership horizon, exit approach and follow-on-capital capacity. The cited Finasens announcement does not disclose purchase price, percentage acquired or detailed financing terms; the cited portfolio page does not disclose transaction value, entry valuation, ownership percentage or financing terms for listed investments.[1][2][3][4][7]
Which Ui Investissement fund and investment activity would apply to the company
Would the contemplated investment be minority or majority
What current revenue, EBITDA, valuation and ownership parameters apply to the relevant investment vehicle
What companies does Ui Investissement target?
Ui Investissement states that it supports startups, SMEs and ETIs and invests in non-listed companies. For capital development and LBO, its publicly stated investment-ticket range is €1 million to €50 million.
The cited official investment-strategy page does not publish a universal current minimum-revenue threshold, EBITDA threshold, valuation range, required ownership percentage or expected holding period.[1][2]
The firm identifies health, agro-business and services-industry as its three principal areas of sector expertise.[3]
Ui Investissement states that it supports non-listed SMEs and ETIs throughout France. It emphasizes regional anchoring through more than 10 regional locations in addition to Paris.[1]
Ui Investissement identifies consolidation as one of its three publicly stated investment activities, alongside capital development and transmission/LBO and innovation capital.[2]
The official portfolio page lists 399 companies as in portfolio and 234 companies as exited, with investments organized by status, investment type, sector and region. Named investments include Finasens, S4E Software-related portfolio exposure, Ekkia, Cyllene, DomusVi, Daco Bello and Neftys Pharma.[4]
On September 14, 2026, Ui Investissement announced that CapExpertis had associated with the firm to accelerate its development and support a transmission to Nicolas Vieille. On September 8, 2026, Ui announced that it accompanied the independence of S4E Software through the FPCI Cap Grand Ouest 3, alongside management and employees.
On September 2, 2026, Ui announced a primary LBO investment in Finasens alongside its historical shareholders, who retained majority ownership.[5][6][7]
What is not clear from Ui Investissement's public investment criteria?
The cited official investment-strategy page does not publish a universal current minimum-revenue threshold, EBITDA threshold, valuation range, required ownership percentage or expected holding period.
The cited official Finasens transaction announcement does not disclose the purchase price, percentage acquired or detailed financing terms. The cited official portfolio page does not disclose transaction value, entry valuation, ownership percentage or financing terms for listed investments.[2][4][7]
Questions to ask when evaluating Ui Investissement as a buyer or investment partner
Which Ui Investissement fund and investment activity would apply to the company?
Would the contemplated investment be minority or majority?
What current revenue, EBITDA, valuation and ownership parameters apply to the relevant investment vehicle?
What governance, management-equity and reporting requirements would apply?
What ownership horizon and exit approach would apply?
How much follow-on capital could be available for acquisitions or organic growth?
What purchase price, financing terms and ownership percentage would apply to the transaction?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Industry / market focus
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Structure / regulatory context
- Structure / regulatory context
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.
